查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1838488

胜肽受體放射性核種治療市場分析與預測（2034年）：類型、產品、服務、技術、應用、最終使用者、流程、階段、模式

Peptide Receptor Radionuclide Therapy Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Process, Stage, Mode
出版日期: | 出版商: Global Insight Services | 英文 382 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

胜肽受體放射性核種治療市場預計將從 2024 年的 38 億美元擴大到 2034 年的 488 億美元，複合年成長率約為 29.1%。胜肽受體放射性核素治療 (PRRT) 市場涉及利用放射性標記胜肽精確靶向和摧毀癌細胞的治療方法。這種創新方法主要用於神經內分泌腫瘤，與傳統治療方法相比，療效更高，副作用更小。放射性藥物的進步、標靶癌症發生率的上升以及醫療保健專業人員意識的提高推動了市場的發展。隨著個人化醫療需求的不斷成長，PRRT 具有巨大的成長潛力，促使人們投資研發以提高治療效果。

受標靶癌症治療技術進步的推動，胜肽受體放射性核素治療 (PRRT) 市場正經歷強勁成長。由於臨床應用的增加和良好的治療效果，神經內分泌腫瘤領域佔據主導地位。在這一領域，生長抑制素類似物因其能有效靶向特定腫瘤受體而表現最佳。前列腺癌治療位居第二，新型配體和放射性藥物的開發已成功。尤其是基於鎦-177 的治療方法引起了人們的關注，並在延長患者生存期方面顯示出良好的效果。癌症發生率的上升和對個人化醫療的需求進一步推動了 PRRT 市場的擴張。不斷加強的研發活動著重於提高治療精準度和最大限度地減少副作用。製藥公司和研究機構之間的合作正在推動技術創新，從而推出下一代放射性配體。監管部門的核准和優惠的報銷政策預計將加速市場滲透，為相關人員提供有利可圖的機會。

市場區隔
類型 鎦-177、釔-90
產品 放射性藥物、輸送裝置
服務 治療計劃、病患監測和諮詢
科技 標靶治療、放射性同位素治療
目的 神經內分泌腫瘤、攝護腺癌、胃腸道胰臟腫瘤
最終用戶 醫院、專科診所、門診手術中心、學術和研究機構
流程 合成、品管、包裝
階段 臨床試驗、商業階段、研發
模式 住院、門診病人

市場概述

胜肽受體放射性核種治療市場在市場佔有率、定價和產品創新方面正經歷動態變化。各公司正專注於透過產品推出組合，推動價格競爭策略。市場正在見證老牌參與者和新進者日益成長的興趣，他們試圖利用胜肽受體放射性核素治療的巨大治療潛力。這種競爭格局正在培育技術創新環境，在研發方面投入大量資金以提高產品的功效和安全性。競爭基準化分析揭示了各種各樣的參與者，每個參與者都試圖透過策略夥伴關係和技術進步來增強其競爭地位。監管影響巨大，嚴格的指導方針塑造市場動態，尤其是在北美和歐洲。這些法規確保安全性和有效性，並影響市場進入和擴大策略。市場的成長軌跡是由對標靶癌症治療的需求不斷成長、人口老化以及核醫學的進步所驅動的。隨著法律規範的發展，它們將在塑造市場機會和挑戰方面發揮關鍵作用。

主要趨勢和促進因素：

受標靶癌症治療技術的進步推動，胜肽受體放射性核素治療 (PRRT) 市場正經歷強勁成長。一個關鍵趨勢是擴大採用個人化醫療來提高治療效果並最大限度地減少副作用。這一趨勢是由神經內分泌腫瘤發生率的上升和對精準治療性介入的需求所驅動。此外，放射性藥物的技術創新正在推動市場擴張。改進的成像技術和新型同位素正在改善治療效果和患者生活品質。新型 PRRT 藥物的監管核准正在加速市場滲透，為患者提供更多的治療選擇。對非侵入性治療方法日益成長的需求也是一個主要驅動力。患者和醫療保健提供者越來越傾向於能夠帶來有效結果的微創治療方法。此外，製藥公司在研發方面不斷增加的投資正在刺激新治療標靶的發現。這些投資為 PRRT 領域的市場參與者創造了有利可圖的機會。

限制與挑戰：

胜肽受體放射性核種治療市場面臨幾個重大的市場限制和挑戰。一個主要的挑戰是開發和生產放射性核素療法的高成本，限制了許多醫療服務提供者和患者的使用。需要專門的基礎設施和設備來安全地處理和管理這些治療方法，這進一步加劇了這種經濟障礙。此外，缺乏接受放射性核種治療細節訓練的熟練專業人員，造成了服務提供的瓶頸。監管障礙也是一個重大挑戰，因為嚴格的核准程序減緩了新治療方法的市場推廣。此外，缺乏關於這些療法的有效性和安全性的全面長期數據可能會阻礙醫療專業人員採用它們。最後，來自免疫療法和標靶治療等替代癌症療法的競爭對市場成長構成了挑戰，這些療法為患者和醫療服務提供者提供了不同的治療選擇。這些因素正在限制胜肽受體放射性核素治療市場的擴張。

主要企業

先進加速器應用、ITM 同位素技術慕尼黑、Clarity Pharmaceuticals、RadioMedix、核子醫學合作夥伴、Telix Pharmaceuticals、Navidea Biopharmaceuticals、Molecular Insight Pharmaceuticals、Isotopia Molecular Imaging、Lantheus Medical Imaging、Progenics Pharmaceuticals、Chouma、Sakakans Biopeak、Mmeric​​ans、Makkak 或Makaks Bioakaks Bioakaks Biopeakaks Biopeakaks Biopeaks​​an Biopeaks、CakMi​​geni​​u​​dis、Projgenics Pharmaceuticals、Cakjumma'amaks Biopeakaks Biopeakx​​an Biopeaks、Cakjumaks Biopeak、Makaks Biopeako​​ans Biopeak、Makaks Biopeako​​anaks Biopeak、Micako​​i Bioakic​​an、Makicin​​ Biotras、Cakakans Biopeak、Mic​​Matakic​​geni​​geni​​ci

目錄

第 1 章胜肽受體放射性核種治療市場概述

  • 調查目的
  • 胜肽受體放射性核種治療市場定義與研究範圍
  • 報告限制
  • 調查年份和貨幣
  • 調查方法

第2章執行摘要

第3章：重要考察

4. 胜肽受體放射性核種治療市場展望

  • 胜肽受體放射性核種治療市場細分
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 價值鏈分析
  • 4P模型
  • 安索夫矩陣

第5章胜肽受體放射性核種治療市場策略

  • 母市場分析
  • 供需分析
  • 消費者購買意向
  • 案例研究分析
  • 定價分析
  • 監管狀況
  • 供應鏈分析
  • 競爭產品分析
  • 近期動態

第6章胜肽受體放射性核種治療的市場規模

  • 胜肽受體放射性核種治療市場規模（按價值）
  • 胜肽受體放射性核種治療市場規模（按數量）

7. 胜肽受體放射性核種治療市場（依類型）

  • 市場概況
  • 鎦-177
  • 釔-90
  • 其他

8. 胜肽受體放射性核種治療市場（依產品）

  • 市場概況
  • 放射性藥物
  • 輸送裝置
  • 其他

9. 胜肽受體放射性核種治療市場（依服務）

  • 市場概況
  • 治療計劃
  • 病患監測
  • 諮詢
  • 其他

10. 胜肽受體放射性核種治療市場（依技術）

  • 市場概況
  • 標靶治療
  • 放射性同位素治療
  • 其他

11. 胜肽受體放射性核種治療市場（依應用）

  • 市場概況
  • 神經內分泌腫瘤
  • 攝護腺癌
  • 消化系統和胰臟腫瘤
  • 其他

12. 胜肽受體放射性核種治療市場（依最終用戶）

  • 市場概況
  • 醫院
  • 專科診所
  • 門診手術中心
  • 學術研究機構
  • 其他

13. 胜肽受體放射性核種治療市場（依製程）

  • 市場概況
  • 合成
  • 品管
  • 包裝
  • 其他

14. 胜肽受體放射性核種治療市場（按階段）

  • 市場概況
  • 臨床試驗
  • 商業階段
  • 研發階段
  • 其他

15. 胜肽受體放射性核種治療市場（按模式）

  • 市場概況
  • 住院病人
  • 門診病人
  • 其他

16. 胜肽受體放射性核種治療市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 瑞典
    • 瑞士
    • 丹麥
    • 芬蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 新加坡
    • 印尼
    • 台灣
    • 馬來西亞
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

第17章競爭格局

  • 概述
  • 市佔率分析
  • 主要企業定位
  • 衝突領導地圖
  • 供應商基準化分析
  • 發展策略基準化分析

第18章：公司簡介

  • Advanced Accelerator Applications
  • ITM Isotope Technologies Munich
  • Clarity Pharmaceuticals
  • RadioMedix
  • Nuclear Medicine Partners
  • Telix Pharmaceuticals
  • Navidea Biopharmaceuticals
  • Molecular Insight Pharmaceuticals
  • Isotopia Molecular Imaging
  • Lantheus Medical Imaging
  • Progenics Pharmaceuticals
  • Curium Pharma
  • Sofie Biosciences
  • Scintomics
  • Jubilant Radiopharma
簡介目錄
Product Code: GIS34123

Peptide Receptor Radionuclide Therapy Market is anticipated to expand from $3.8 billion in 2024 to $48.8 billion by 2034, growing at a CAGR of approximately 29.1%. The Peptide Receptor Radionuclide Therapy (PRRT) Market encompasses treatments that utilize radiolabeled peptides to target and destroy cancer cells with high precision. This innovative approach is primarily used for neuroendocrine tumors, offering improved efficacy and minimal side effects compared to conventional therapies. The market is driven by advancements in radiopharmaceuticals, increasing incidence of targetable cancers, and growing awareness among healthcare professionals. As demand for personalized medicine rises, PRRT presents significant growth potential, encouraging investment in research and development to enhance therapeutic outcomes.

The Peptide Receptor Radionuclide Therapy (PRRT) Market is experiencing robust growth, fueled by advancements in targeted cancer therapies. The segment of neuroendocrine tumors dominates, benefiting from increased clinical adoption and favorable outcomes. Within this segment, somatostatin analogs are the top-performing sub-segment, driven by their efficacy in targeting specific tumor receptors. The second highest performing segment is the treatment of prostate cancer, capitalizing on the development of novel ligands and radiopharmaceuticals. Lutetium-177 based therapies are particularly noteworthy, offering promising results in extending patient survival rates. The increasing prevalence of cancer and the demand for personalized medicine further propel PRRT's market expansion. Research and development activities are intensifying, focusing on enhancing therapy precision and minimizing side effects. Collaborations between pharmaceutical companies and research institutions are fostering innovation, leading to the introduction of next-generation radioligands. Regulatory approvals and favorable reimbursement policies are anticipated to accelerate market penetration, offering lucrative opportunities for stakeholders.

Market Segmentation
TypeLutetium-177, Yttrium-90
ProductRadiopharmaceuticals, Delivery Devices
ServicesTreatment Planning, Patient Monitoring, Consultation
TechnologyTargeted Therapy, Radioisotope Therapy
ApplicationNeuroendocrine Tumors, Prostate Cancer, Gastroenteropancreatic Tumors
End UserHospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic and Research Institutes
ProcessSynthesis, Quality Control, Packaging
StageClinical Trials, Commercial Stage, Research and Development
ModeInpatient, Outpatient

Market Snapshot:

The Peptide Receptor Radionuclide Therapy Market is experiencing a dynamic shift in market share, pricing, and product innovation. Companies are focusing on expanding their portfolio with new product launches, which are driving competitive pricing strategies. The market is witnessing increased interest from both established players and new entrants, aiming to capitalize on the promising therapeutic potential of peptide receptor radionuclide therapies. This competitive landscape is fostering an environment of innovation, with significant investments in research and development to enhance product efficacy and safety. Competition benchmarking reveals a diverse array of players, each striving for a competitive edge through strategic partnerships and technological advancements. Regulatory influences are pivotal, with stringent guidelines shaping market dynamics, particularly in North America and Europe. These regulations ensure safety and efficacy, influencing market entry and expansion strategies. The market's growth trajectory is bolstered by rising demand for targeted cancer therapies, a growing geriatric population, and advancements in nuclear medicine. As regulatory frameworks evolve, they will continue to play a critical role in shaping market opportunities and challenges.

Geographical Overview:

The Peptide Receptor Radionuclide Therapy (PRRT) market is witnessing remarkable growth across diverse regions, each presenting unique opportunities. North America is at the forefront, driven by advanced healthcare infrastructure and substantial investments in cancer research. The United States, in particular, is a key player, with a strong focus on innovation and clinical trials. Europe follows closely, with countries like Germany and the United Kingdom leading in the adoption of PRRT. The region's robust healthcare systems and emphasis on personalized medicine contribute to its market strength. In Asia Pacific, the market is expanding rapidly, propelled by increasing cancer prevalence and healthcare advancements. China and India are emerging as significant growth pockets, investing heavily in healthcare infrastructure. Latin America and the Middle East & Africa are promising markets with growing potential. Brazil is witnessing increased healthcare investments, while the Middle East & Africa are recognizing the benefits of PRRT in enhancing cancer treatment outcomes.

Key Trends and Drivers:

The Peptide Receptor Radionuclide Therapy (PRRT) market is experiencing robust growth, fueled by advancements in targeted cancer therapies. A significant trend is the increasing adoption of personalized medicine, which enhances treatment efficacy and minimizes side effects. This trend is driven by the growing prevalence of neuroendocrine tumors and the need for precise therapeutic interventions. Moreover, technological innovations in radiopharmaceuticals are propelling market expansion. Enhanced imaging techniques and novel isotopes are improving treatment outcomes and patient quality of life. Regulatory approvals for new PRRT agents are accelerating market penetration, providing patients with more treatment options. The rising demand for non-invasive treatment modalities is another key driver. Patients and healthcare providers are increasingly favoring therapies that offer effective results with minimal invasiveness. Additionally, increasing investments in research and development by pharmaceutical companies are fostering the discovery of new therapeutic targets. This investment is creating lucrative opportunities for market players in the PRRT sector.

Restraints and Challenges:

The Peptide Receptor Radionuclide Therapy Market is confronted with several significant restraints and challenges. A primary challenge is the high cost associated with the development and production of radionuclide therapies, which limits accessibility for many healthcare providers and patients. This financial barrier is exacerbated by the need for specialized infrastructure and equipment to handle and administer these therapies safely. Furthermore, there is a scarcity of skilled professionals trained in the nuances of radionuclide therapy, creating a bottleneck in service delivery. Regulatory hurdles also pose a significant challenge, as stringent approval processes can delay the introduction of new therapies to the market. Additionally, there is a lack of comprehensive long-term data on the efficacy and safety of these treatments, which can hinder adoption by healthcare practitioners. Lastly, competition from alternative cancer therapies, such as immunotherapy and targeted therapies, presents a challenge to market growth by offering patients and providers different treatment options. These factors collectively impede the expansion of the Peptide Receptor Radionuclide Therapy Market.

Key Players:

Advanced Accelerator Applications, ITM Isotope Technologies Munich, Clarity Pharmaceuticals, RadioMedix, Nuclear Medicine Partners, Telix Pharmaceuticals, Navidea Biopharmaceuticals, Molecular Insight Pharmaceuticals, Isotopia Molecular Imaging, Lantheus Medical Imaging, Progenics Pharmaceuticals, Curium Pharma, Sofie Biosciences, Scintomics, Jubilant Radiopharma

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Peptide Receptor Radionuclide Therapy Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Peptide Receptor Radionuclide Therapy Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Process
  • 2.10 Key Highlights of the Market, by Stage
  • 2.11 Key Highlights of the Market, by Mode
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Process
  • 3.9 Market Attractiveness Analysis, by Stage
  • 3.10 Market Attractiveness Analysis, by Mode
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Peptide Receptor Radionuclide Therapy Market Outlook

  • 4.1 Peptide Receptor Radionuclide Therapy Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Peptide Receptor Radionuclide Therapy Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Peptide Receptor Radionuclide Therapy Market Size

  • 6.1 Peptide Receptor Radionuclide Therapy Market Size, by Value
  • 6.2 Peptide Receptor Radionuclide Therapy Market Size, by Volume

7: Peptide Receptor Radionuclide Therapy Market, by Type

  • 7.1 Market Overview
  • 7.2 Lutetium-177
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Yttrium-90
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Others
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region

8: Peptide Receptor Radionuclide Therapy Market, by Product

  • 8.1 Market Overview
  • 8.2 Radiopharmaceuticals
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Delivery Devices
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Others
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region

9: Peptide Receptor Radionuclide Therapy Market, by Services

  • 9.1 Market Overview
  • 9.2 Treatment Planning
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Patient Monitoring
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Consultation
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Others
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region

10: Peptide Receptor Radionuclide Therapy Market, by Technology

  • 10.1 Market Overview
  • 10.2 Targeted Therapy
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Radioisotope Therapy
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Others
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region

11: Peptide Receptor Radionuclide Therapy Market, by Application

  • 11.1 Market Overview
  • 11.2 Neuroendocrine Tumors
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Prostate Cancer
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Gastroenteropancreatic Tumors
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Others
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region

12: Peptide Receptor Radionuclide Therapy Market, by End User

  • 12.1 Market Overview
  • 12.2 Hospitals
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Specialty Clinics
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Ambulatory Surgical Centers
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Academic and Research Institutes
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Others
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region

13: Peptide Receptor Radionuclide Therapy Market, by Process

  • 13.1 Market Overview
  • 13.2 Synthesis
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Quality Control
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Packaging
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Others
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region

14: Peptide Receptor Radionuclide Therapy Market, by Stage

  • 14.1 Market Overview
  • 14.2 Clinical Trials
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Commercial Stage
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Research and Development
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Peptide Receptor Radionuclide Therapy Market, by Mode

  • 15.1 Market Overview
  • 15.2 Inpatient
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Outpatient
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: Peptide Receptor Radionuclide Therapy Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Application
    • 16.2.7 North America Market Size and Forecast, by End User
    • 16.2.8 North America Market Size and Forecast, by Process
    • 16.2.9 North America Market Size and Forecast, by Stage
    • 16.2.10 North America Market Size and Forecast, by Mode
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Application
      • 16.2.9.6 United States Market Size and Forecast, by End User
      • 16.2.9.7 United States Market Size and Forecast, by Process
      • 16.2.9.8 United States Market Size and Forecast, by Stage
      • 16.2.9.9 United States Market Size and Forecast, by Mode
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Application
      • 16.2.10.6 Canada Market Size and Forecast, by End User
      • 16.2.10.7 Canada Market Size and Forecast, by Process
      • 16.2.10.8 Canada Market Size and Forecast, by Stage
      • 16.2.10.9 Canada Market Size and Forecast, by Mode
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Application
    • 16.3.7 Europe Market Size and Forecast, by End User
    • 16.3.8 Europe Market Size and Forecast, by Process
    • 16.3.9 Europe Market Size and Forecast, by Stage
    • 16.3.10 Europe Market Size and Forecast, by Mode
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Process
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Stage
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Mode
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Application
      • 16.3.10.6 Germany Market Size and Forecast, by End User
      • 16.3.10.7 Germany Market Size and Forecast, by Process
      • 16.3.10.8 Germany Market Size and Forecast, by Stage
      • 16.3.10.9 Germany Market Size and Forecast, by Mode
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Application
      • 16.3.11.6 France Market Size and Forecast, by End User
      • 16.3.11.7 France Market Size and Forecast, by Process
      • 16.3.11.8 France Market Size and Forecast, by Stage
      • 16.3.11.9 France Market Size and Forecast, by Mode
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Application
      • 16.3.12.6 Spain Market Size and Forecast, by End User
      • 16.3.12.7 Spain Market Size and Forecast, by Process
      • 16.3.12.8 Spain Market Size and Forecast, by Stage
      • 16.3.12.9 Spain Market Size and Forecast, by Mode
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Application
      • 16.3.13.6 Italy Market Size and Forecast, by End User
      • 16.3.13.7 Italy Market Size and Forecast, by Process
      • 16.3.13.8 Italy Market Size and Forecast, by Stage
      • 16.3.13.9 Italy Market Size and Forecast, by Mode
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Application
      • 16.3.14.6 Netherlands Market Size and Forecast, by End User
      • 16.3.14.7 Netherlands Market Size and Forecast, by Process
      • 16.3.14.8 Netherlands Market Size and Forecast, by Stage
      • 16.3.14.9 Netherlands Market Size and Forecast, by Mode
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Application
      • 16.3.15.6 Sweden Market Size and Forecast, by End User
      • 16.3.15.7 Sweden Market Size and Forecast, by Process
      • 16.3.15.8 Sweden Market Size and Forecast, by Stage
      • 16.3.15.9 Sweden Market Size and Forecast, by Mode
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Application
      • 16.3.16.6 Switzerland Market Size and Forecast, by End User
      • 16.3.16.7 Switzerland Market Size and Forecast, by Process
      • 16.3.16.8 Switzerland Market Size and Forecast, by Stage
      • 16.3.16.9 Switzerland Market Size and Forecast, by Mode
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Application
      • 16.3.17.6 Denmark Market Size and Forecast, by End User
      • 16.3.17.7 Denmark Market Size and Forecast, by Process
      • 16.3.17.8 Denmark Market Size and Forecast, by Stage
      • 16.3.17.9 Denmark Market Size and Forecast, by Mode
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Application
      • 16.3.18.6 Finland Market Size and Forecast, by End User
      • 16.3.18.7 Finland Market Size and Forecast, by Process
      • 16.3.18.8 Finland Market Size and Forecast, by Stage
      • 16.3.18.9 Finland Market Size and Forecast, by Mode
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Application
      • 16.3.19.6 Russia Market Size and Forecast, by End User
      • 16.3.19.7 Russia Market Size and Forecast, by Process
      • 16.3.19.8 Russia Market Size and Forecast, by Stage
      • 16.3.19.9 Russia Market Size and Forecast, by Mode
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Process
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Stage
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Mode
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Process
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Stage
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Mode
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Application
      • 16.4.9.6 China Market Size and Forecast, by End User
      • 16.4.9.7 China Market Size and Forecast, by Process
      • 16.4.9.8 China Market Size and Forecast, by Stage
      • 16.4.9.9 China Market Size and Forecast, by Mode
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Application
      • 16.4.10.6 India Market Size and Forecast, by End User
      • 16.4.10.7 India Market Size and Forecast, by Process
      • 16.4.10.8 India Market Size and Forecast, by Stage
      • 16.4.10.9 India Market Size and Forecast, by Mode
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Application
      • 16.4.11.6 Japan Market Size and Forecast, by End User
      • 16.4.11.7 Japan Market Size and Forecast, by Process
      • 16.4.11.8 Japan Market Size and Forecast, by Stage
      • 16.4.11.9 Japan Market Size and Forecast, by Mode
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Application
      • 16.4.12.6 South Korea Market Size and Forecast, by End User
      • 16.4.12.7 South Korea Market Size and Forecast, by Process
      • 16.4.12.8 South Korea Market Size and Forecast, by Stage
      • 16.4.12.9 South Korea Market Size and Forecast, by Mode
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Application
      • 16.4.13.6 Australia Market Size and Forecast, by End User
      • 16.4.13.7 Australia Market Size and Forecast, by Process
      • 16.4.13.8 Australia Market Size and Forecast, by Stage
      • 16.4.13.9 Australia Market Size and Forecast, by Mode
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Application
      • 16.4.14.6 Singapore Market Size and Forecast, by End User
      • 16.4.14.7 Singapore Market Size and Forecast, by Process
      • 16.4.14.8 Singapore Market Size and Forecast, by Stage
      • 16.4.14.9 Singapore Market Size and Forecast, by Mode
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Application
      • 16.4.15.6 Indonesia Market Size and Forecast, by End User
      • 16.4.15.7 Indonesia Market Size and Forecast, by Process
      • 16.4.15.8 Indonesia Market Size and Forecast, by Stage
      • 16.4.15.9 Indonesia Market Size and Forecast, by Mode
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Application
      • 16.4.16.6 Taiwan Market Size and Forecast, by End User
      • 16.4.16.7 Taiwan Market Size and Forecast, by Process
      • 16.4.16.8 Taiwan Market Size and Forecast, by Stage
      • 16.4.16.9 Taiwan Market Size and Forecast, by Mode
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Application
      • 16.4.17.6 Malaysia Market Size and Forecast, by End User
      • 16.4.17.7 Malaysia Market Size and Forecast, by Process
      • 16.4.17.8 Malaysia Market Size and Forecast, by Stage
      • 16.4.17.9 Malaysia Market Size and Forecast, by Mode
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Application
    • 16.5.7 Latin America Market Size and Forecast, by End User
    • 16.5.8 Latin America Market Size and Forecast, by Process
    • 16.5.9 Latin America Market Size and Forecast, by Stage
    • 16.5.10 Latin America Market Size and Forecast, by Mode
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Application
      • 16.5.9.6 Brazil Market Size and Forecast, by End User
      • 16.5.9.7 Brazil Market Size and Forecast, by Process
      • 16.5.9.8 Brazil Market Size and Forecast, by Stage
      • 16.5.9.9 Brazil Market Size and Forecast, by Mode
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Application
      • 16.5.10.6 Mexico Market Size and Forecast, by End User
      • 16.5.10.7 Mexico Market Size and Forecast, by Process
      • 16.5.10.8 Mexico Market Size and Forecast, by Stage
      • 16.5.10.9 Mexico Market Size and Forecast, by Mode
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Application
      • 16.5.11.6 Argentina Market Size and Forecast, by End User
      • 16.5.11.7 Argentina Market Size and Forecast, by Process
      • 16.5.11.8 Argentina Market Size and Forecast, by Stage
      • 16.5.11.9 Argentina Market Size and Forecast, by Mode
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Process
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Stage
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Mode
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Process
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Stage
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Mode
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Process
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Stage
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Mode
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Application
      • 16.6.10.6 UAE Market Size and Forecast, by End User
      • 16.6.10.7 UAE Market Size and Forecast, by Process
      • 16.6.10.8 UAE Market Size and Forecast, by Stage
      • 16.6.10.9 UAE Market Size and Forecast, by Mode
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Application
      • 16.6.11.6 South Africa Market Size and Forecast, by End User
      • 16.6.11.7 South Africa Market Size and Forecast, by Process
      • 16.6.11.8 South Africa Market Size and Forecast, by Stage
      • 16.6.11.9 South Africa Market Size and Forecast, by Mode
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Process
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Stage
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Mode
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Advanced Accelerator Applications
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 ITM Isotope Technologies Munich
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Clarity Pharmaceuticals
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 RadioMedix
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Nuclear Medicine Partners
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Telix Pharmaceuticals
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Navidea Biopharmaceuticals
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Molecular Insight Pharmaceuticals
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Isotopia Molecular Imaging
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Lantheus Medical Imaging
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Progenics Pharmaceuticals
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Curium Pharma
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Sofie Biosciences
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Scintomics
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Jubilant Radiopharma
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis